Stay updated on Canagliflozin Impact on Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.

Latest updates to the Canagliflozin Impact on Heart Failure Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRecord History was updated to add revision v3.5.0 and remove revision v3.4.3.SummaryDifference0.1%

- Check25 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 in the record history.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page history now includes Revision: v3.4.2; prior notices about funding lapse and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check61 days agoChange DetectedAdded a general notice about government funding status. Updated the site revision tag from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check68 days agoChange DetectedShow glossary option added and color-coding legend updated; 'No FEAR Act Data' removed and site revision updated to v3.4.0.SummaryDifference0.8%

- Check82 days agoChange DetectedThe history shows a new revision entry (v3.3.4) replacing the previous v3.3.3. This update is a backend revision to the page and does not modify study details or results.SummaryDifference0.1%

Stay in the know with updates to Canagliflozin Impact on Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.